{"entity":{"id":"nct03925935","kind":"trial","name":"Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation","aka":[],"tldr":"A phase 1 trial of AB-205 run by Angiocrine Bioscience, completed.","summary":"Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation is a phase 1 interventional study registered as NCT03925935 by Angiocrine Bioscience, with 42 participants enrolled, started 2019-05-07. Conditions recorded: Hodgkin Lymphoma and Non-hodgkin Lymphoma. Interventions recorded: AB-205.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT03925935","url":"https://clinicaltrials.gov/study/NCT03925935"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["hodgkin-lymphoma","non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["ab-205"],"companies":["angiocrine-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03925935","phase":"1","setting":"A Phase 1, Open Label, Non-randomized, Multi-Center Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation","sponsor":"Angiocrine Bioscience","enrolled":42,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03925935/","neighbours":{"cancer":[{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"ab-205","kind":"drug","name":"AB-205","route":"/drugs/ab-205/"}],"company":[{"id":"angiocrine-bioscience","kind":"company","name":"Angiocrine Bioscience","route":"/companies/angiocrine-bioscience/"}]}}